0.12%| Prev Close: | 1.61 |
|---|---|
| Open: | N/A |
| Bid: | 1.52 x 1200 |
| Ask: | 1.75 x 100 |
| 1y Target Est: | 3.67 |
| Beta: | 2.16 |
| Next Earnings Date: | N/A |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 1.20 - 2.95 |
| Volume: | 0 |
| Avg Vol (3m): | 264,415 |
| Market Cap: | 72.17M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.57 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CLEVELAND BIOLABS INC FinancialsEDGAR Online Financials(Fri, May 17)
- 4 Healthcare Stock Stories For Tuesday Investment Wellnessat Wall St. Cheat Sheet(Tue, May 14)
- Cleveland BioLabs and Incuron Announce US and European Patent Allowances for CuraxinsGlobeNewswire(Tue, May 14)
- Cleveland BioLabs' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 9)
- CORRECTION -- Cleveland BioLabs Reports First Quarter 2013 Financial Results and Development ProgressGlobeNewswire(Thu, May 9)
- Cleveland BioLabs Reports First Quarter 2013 Financial Results and Development ProgressGlobeNewswire(Thu, May 9)
- Q1 2013 CLEVELAND BIOLABS INC Earnings Release - Before Market OpenCCBN(Thu, May 9)
- CLEVELAND BIOLABS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or PrincEDGAR Online(Thu, May 9)
- Cleveland BioLabs Announces Appointment of Shareholder Representative to BoardGlobeNewswire(Wed, May 8)
- Isis Initiates ISIS-STAT3 StudyZacks(Tue, May 7)
- Zacks Bull and Bear of the Day Highlights: Private Bancorp, Pan American Silver, AVEO Pharmaceuticals, Astellas Pharma and Cleveland BioLabsZacks(Mon, May 6)
- Negative Opinion on AVEO/ALPMY CandidateZacks(Fri, May 3)
- Loss at Aegerion Narrower Than ExpectedZacks(Fri, May 3)
- Vertex Loss Lower, Kalydeco Outlook UpZacks(Wed, May 1)
- Cleveland BioLabs, Roswell Park Announce Publication of Studies Defining Role of Liver in Activity of Entolimod (CBLB502)GlobeNewswire(Wed, May 1)
Press Releases
- Cleveland BioLabs and Incuron Announce US and European Patent Allowances for CuraxinsGlobeNewswire(Tue, May 14)
- CORRECTION -- Cleveland BioLabs Reports First Quarter 2013 Financial Results and Development ProgressGlobeNewswire(Thu, May 9)
- Cleveland BioLabs Reports First Quarter 2013 Financial Results and Development ProgressGlobeNewswire(Thu, May 9)
Reports
- CBLI: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 21)
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(May 21)
- CLEVELAND BIOLABS INC (CBLI) 12-months forecastPechala's Reports(May 18)